+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2025-2030- Product Image
Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2025-2030- Product Image
Sale

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127400
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nuclear medicine and radiopharmaceuticals market is positioned for significant transformation, propelled by rapid technological advancements, evolving regulatory frameworks, and emerging collaborative models. Senior executives need a clear understanding of the sector’s evolving landscape to identify opportunity, manage risk, and guide strategic investments.

Market Snapshot: Nuclear Medicine and Radiopharmaceuticals

With healthcare’s growing emphasis on precision diagnostics and targeted therapeutics, nuclear medicine and radiopharmaceuticals have become central to modern clinical pathways. The market is supported by innovations in molecular imaging—particularly PET and SPECT technologies—along with a rising demand for personalized medicine and disease management at earlier stages. The sector also benefits from increasing cross-disciplinary partnerships among research institutes, biotechnology players, and medical device manufacturers.

Scope & Segmentation

The report provides comprehensive coverage across the spectrum of nuclear medicine and radiopharmaceutical applications, technologies, and regions:

  • Product Types: Diagnostic radiopharmaceuticals, including PET (F-18, Ga-68 tracers) and SPECT (Tc-99m and non-Tc-99m agents); and therapeutic radiopharmaceuticals, comprising alpha emitters (Ra-223 therapies) and beta emitters (I-131, Lu-177, Y-90 therapies).
  • Applications: Bone imaging, cardiology, neurology, oncology, and inflammation imaging, each demanding diverse tracer characteristics and safety profiles.
  • End Users: Ambulatory care facilities, hospital radiology departments, research organizations, and diagnostic imaging centers, encompassing the entire healthcare delivery ecosystem.
  • Distribution Channels: Direct sales, indirect sales, and online channels, each impacting market penetration and customer reach.
  • Isotope Types: Cyclotron-produced isotopes (C-11, F-18), and generator-based isotopes (Ge-68/Ga-68, Mo-99/Tc-99m), reflecting varied supply chain and regulatory requirements.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, UAE, South Africa, among others), Asia-Pacific (such as China, India, Japan, Australia, and more).
  • Key Companies: GE Healthcare Limited, Siemens Healthcare GmbH, Koninklijke Philips N.V., Cardinal Health, Inc., Lantheus Holdings, Inc., Bracco Imaging S.p.A., Bayer AG, Curium Pharma LUX S.à r.l., Jubilant Radiopharma Limited, Eckert & Ziegler Strahlen- und Medizintechnik AG.

Key Takeaways

  • Advances in molecular imaging, isotope production, and radiolabeling are raising the standard of care by enabling precise detection and therapy at the molecular level.
  • The integration of artificial intelligence in PET/CT and SPECT/CT systems enhances image quality, supports workflow efficiency, and streamlines lesion identification for clinicians.
  • Regulatory collaboration and adaptive trial designs are gaining traction, supporting the faster clinical validation and approval of next-generation radiopharmaceutical agents.
  • Cross-sector partnerships between biotech innovators, device manufacturers, and academic centers foster innovation while ensuring greater speed to market for novel tracers and therapies.
  • Regional dynamics such as expanding domestic isotope production in Asia-Pacific and value-based pricing in Western Europe are shaping tailored growth strategies and fostering local partnerships.
  • Supply chain resilience and cost management remain strategic priorities in response to policy changes and growing complexity in raw material sourcing.

Nuclear Medicine and Radiopharmaceuticals: Tariff Impact in the United States

Recent tariff measures introduced in the United States have disrupted global radiopharmaceutical supply chains. These policies have raised material costs and created procurement uncertainties for production centers, prompting an industry-wide reevaluation of sourcing strategies and investment in domestic capabilities. Both research groups and manufacturers are responding by expanding in-house isotope production and forming alliances with regional suppliers, strengthening long-term resilience.

Methodology & Data Sources

This analysis leverages robust secondary research, including scientific literature, regulatory filings, and conference material, complemented by primary insights from interviews with industry leaders and clinicians. Data triangulation and validation workshops with independent experts ensure the reliability and relevance of findings throughout the report.

Why This Report Matters

  • Supports strategic planning with actionable insights on market segmentation, technology adoption, and regulatory outlook.
  • Equips leaders with a nuanced view of global supply chains and the competitive landscape, enabling tailored growth strategies.
  • Facilitates informed decision-making on partnership opportunities, investment priorities, and market entry across diverse geographies.

Conclusion

The nuclear medicine and radiopharmaceuticals market is evolving through continual innovation and structured collaboration. Organizations able to adapt and invest strategically are well positioned to capture future growth and deliver clinical value.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of automation in radiochemistry synthesis to increase radiopharmaceutical throughput and consistency
5.2. Integration of theranostic approaches combining diagnostic isotopes with targeted therapeutic radionuclides in clinical pipelines
5.3. Development of novel chelators for stable gallium-68 and zirconium-89 labeling to improve in vivo imaging accuracy
5.4. Adoption of cold kits for rapid point-of-care radiopharmaceutical preparation in community hospitals and outpatient clinics
5.5. Implementation of microfluidic-based radiotracer production to reduce precursor consumption and regulatory complexities
5.6. Strategic partnerships between biotech firms and cyclotron manufacturers to scale 18F and 11C tracer availability
5.7. Regulatory harmonization initiatives aiming to streamline radiopharmaceutical approval across multiple jurisdictions
5.8. Growing investment in alpha-emitter therapies such as actinium-225 for treatment-resistant metastatic cancers
5.9. Use of AI-driven image analysis tools to enhance quantitative nuclear medicine diagnostics and personalized treatment planning
5.10. Expansion of decentralized cyclotron networks to support on-demand production of short-lived positron emitters
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nuclear Medicine & Radiopharmaceuticals Market, by Product Type
8.1. Introduction
8.2. Diagnostic Radiopharmaceuticals
8.2.1. PET Radiopharmaceuticals
8.2.1.1. F-18 Radiopharmaceuticals
8.2.1.2. Ga-68 Radiopharmaceuticals
8.2.2. SPECT Radiopharmaceuticals
8.2.2.1. Non Tc-99m Radiopharmaceuticals
8.2.2.2. Tc-99m Radiopharmaceuticals
8.3. Therapeutic Radiopharmaceuticals
8.3.1. Alpha Emitting Radiopharmaceuticals
8.3.1.1. Ra-223 Therapies
8.3.2. Beta Emitting Radiopharmaceuticals
8.3.2.1. I-131 Based Therapies
8.3.2.2. Lu-177 Based Therapies
8.3.2.3. Y-90 Based Therapies
9. Nuclear Medicine & Radiopharmaceuticals Market, by Application
9.1. Introduction
9.2. Bone Imaging
9.3. Cardiology
9.4. Inflammation Imaging
9.5. Neurology
9.6. Oncology
10. Nuclear Medicine & Radiopharmaceuticals Market, by End User
10.1. Introduction
10.2. Ambulatory Care Facilities
10.3. Diagnostic Imaging Centers
10.4. Hospital Radiology Departments
10.5. Research Organizations
11. Nuclear Medicine & Radiopharmaceuticals Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Indirect Sales
11.4. Online Channels
12. Nuclear Medicine & Radiopharmaceuticals Market, by Isotope Type
12.1. Introduction
12.2. Cyclotron Produced Isotopes
12.2.1. C-11
12.2.2. F-18
12.3. Generator Based Isotopes
12.3.1. Ge-68 Ga-68 Generators
12.3.2. Mo-99 Tc-99m Generators
13. Americas Nuclear Medicine & Radiopharmaceuticals Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. GE Healthcare Limited
16.3.2. Siemens Healthcare GmbH
16.3.3. Koninklijke Philips N.V.
16.3.4. Cardinal Health, Inc.
16.3.5. Lantheus Holdings, Inc.
16.3.6. Bracco Imaging S.p.A.
16.3.7. Bayer AG
16.3.8. Curium Pharma LUX S.à r.l.
16.3.9. Jubilant Radiopharma Limited
16.3.10. Eckert & Ziegler Strahlen- und Medizintechnik AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET: RESEARCHAI
FIGURE 26. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET: RESEARCHSTATISTICS
FIGURE 27. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET: RESEARCHCONTACTS
FIGURE 28. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18 RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18 RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GA-68 RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GA-68 RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NON TC-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NON TC-99M RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223 THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223 THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY I-131 BASED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY I-131 BASED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177 BASED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177 BASED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90 BASED THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90 BASED THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BONE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BONE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATION IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATION IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY CARE FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL RADIOLOGY DEPARTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL RADIOLOGY DEPARTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY INDIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY C-11, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY C-11, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GE-68 GA-68 GENERATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GE-68 GA-68 GENERATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY MO-99 TC-99M GENERATORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY MO-99 TC-99M GENERATORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 158. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 159. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 160. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 161. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 162. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 163. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 164. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 165. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 166. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 167. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 168. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 169. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2024 (USD MILLION)
TABLE 176. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025-2030 (USD MILLION)
TABLE 177. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 178. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 179. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 180. CANADA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 181. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 204. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 205. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 206. MEXICO NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTING RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED ISOTOPES, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE & RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Nuclear Medicine & Radiopharmaceuticals market report include:
  • GE Healthcare Limited
  • Siemens Healthcare GmbH
  • Koninklijke Philips N.V.
  • Cardinal Health, Inc.
  • Lantheus Holdings, Inc.
  • Bracco Imaging S.p.A.
  • Bayer AG
  • Curium Pharma LUX S.à r.l.
  • Jubilant Radiopharma Limited
  • Eckert & Ziegler Strahlen- und Medizintechnik AG

Related Topics

Related Reports

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2025-2030 - Product Image

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Radiopharmaceutical for Nuclear Medicine Market - Global Forecast 2025-2030 - Product Image

Radiopharmaceutical for Nuclear Medicine Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034) - Product Image

Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Nuclear Medicine Market Report and Forecast 2025-2034 - Product Image

Nuclear Medicine Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.